For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

Date published: January 2008
When you are considering a new medicine, it is important to weigh up the expected benefits and the possible risks of the new medicine, compared with other available medicines or treatments.
Remember that risks and benefits differ between medicines and from person to person.
Your doctor can help you compare different medicines and treatments to decide what is best for your particular situation.
3. Other medicines available for this condition
4. How well it works compared with other medicines
5. Important side effects to consider
6. How to reduce your risk of side effects
7. What else you should know about this medicine
8. Who can be prescribed this medicine on the PBS
9. Other ways to help this condition
10. How new medicines are tested and approved for use in Australia
The active ingredient is the chemical in the medicine that makes the medicine work.
Active ingredient: Alendronate (pronounced ‘a-LEN-drun-ATE’)
Brand names:
Fosamax Once Weekly and Alendro Once Weekly contain alendronate only.
Fosamax Plus contains two active ingredients - alendronate and vitamin D3 .
Alendronate is a type of medicine called a bisphosphonate (‘bis-fos-fo-nate’).
Bisphosphonates are used to treat fragile bones (osteoporosis) and prevent fractures (broken bones).
Vitamin D is an essential substance for forming and maintaining strong bones.
Bone Mineral Density (BMD) tests measure how thin bones are.
Osteoporosis is a condition which causes bones to become fragile and brittle. If you have osteoporosis you are at risk of fractures, most commonly in the hips, spine (backbone) and wrist. These fractures can lead to long-term pain and the loss of independence.
Osteoporosis is more common in women, especially after menopause, but it can occur in men. Osteoporosis may also sometimes be caused by long-term use of some corticosteroid medicines, such as prednisolone, used for asthma and some rheumatic conditions.
Alendronate works by slowing bone thinning and allowing new bone to rebuild and strengthen. Bone strength is usually measured by a Bone Mineral Density (BMD) scan, which indicates the amount of calcium in your bones. A BMD scan is sometimes called a DXA scan.
This scan is quick and painless, like an X-ray. A BMD scan measures the density of your bones and compares the result to the bone density of an average young adult. The result is called a T-score. If you have osteoporosis your T-score will be minus 2.5 or lower. The lower your T-score the greater your risk of fracture, that is, a score of minus 3 is worse than a score of minus 2.5. Treatment with alendronate can increase your BMD and reduce your risk of breaking a bone.
However, a low BMD is not the only thing that determines your risk of fracturing (breaking) a bone. There are other risk factors for fracture too. We discuss some of the ways you can reduce your risk of fracture in Section 9: "Other ways to help this condition".
The most important risk factors, besides a low BMD, are:
For this reason, people who have already suffered a fracture caused by osteoporosis, have a low BMD, and/or are over 70 years of age will benefit the most from treatment with a medicine for osteoporosis.
Talk with your doctor about all of the treatment options for osteoporosis.
Other medicines are available in Australia for the treatment of osteoporosis. Some of these are also bisphosphonates:
Others are not:
Some medicines for osteoporosis can only be prescribed for you on the Pharmaceutical Benefits Scheme (PBS) after you have had a fracture caused by osteoporosis. People who have already suffered a fracture are at the greatest risk of further fractures and therefore they get the most benefit from these medicines.
However, as of 1 April 2007, you may be eligible to receive alendronate on the PBS if you have osteoporosis but have not yet had a fracture. To qualify, you must be over 70 years of age and have had a Bone Mineral Density scan that shows that you have fragile bones (see Section 9: "Who can be prescribed this medicine on the PBS"). Alternative medicines are risedronate (Actonel) and strontium (Protos).
Hormone replacement therapy (HRT) was used in the past to prevent fractures in women with osteoporosis. However, HRT can slightly increase the risk of heart disease, stroke and breast cancer, so it is now only recommended for the short-term treatment of menopausal symptoms
Calcium and vitamin D are also important for healthy bones. If you don’t have enough calcium in your diet your doctor may recommend that you take calcium supplements. If you are unwell from any condition which means you cannot get outdoors much, or are dark-skinned or need to cover your head and body for cultural reasons, you may also need a vitamin D supplement. However, calcium and vitamin D alone are probably not enough to prevent fractures in people who have had a previous fracture.
A clinical trial is a research study conducted with patients, which tests out a drug or other intervention
to assess its effectiveness and safety.
For more information on clinical trials see Section 10: “How new medicines are tested and approved for use in Australia”.
A number of osteoporosis medicines, including alendronate, have been shown in clinical research trials to reduce the risk of new fractures in people who have already suffered a fracture as a result of osteoporosis. But, as yet, alendronate is one of the few medicines where there is good evidence to show that it can also prevent fractures in people with osteoporosis who have not yet suffered a fracture.
Alendronate was compared with a placebo (an inactive or “sugar” tablet) in two large clinical trials and found to reduce the risk of fracture.
1. In the first trial, the subjects were postmenopausal women with osteoporosis who had already had a fracture of the spine detected on x-ray.In this trial, 2027 women aged 55–81 years were followed up for 3 years. Approximately half the women received alendronate and the rest received a placebo. Amongst women who were treated with alendronate, 8% had a new spinal fracture detected by x-ray, compared with 15% of women who received the placebo. Alendronate also reduced the risk of other fractures of the spine, hip and wrist.
2. In the second trial the subjects were postmenopausal women who had not yet had a fracture but who were at high risk of doing so because of low bone mineral density.
This trial included over 4200 women, aged 54–81 years, who were followed up for four years. In women with low BMD (T score ≤ -2.5), alendronate reduced the percentage of women who had any fracture from 20% to 13% and the percentage who had spinal fractures on x-ray was reduced from 6% to 3%, when compared with the placebo.
It is important to note that alendronate cannot prevent all fractures in people with osteoporosis. In addition, most of the women in the alendronate trials did not have enough calcium in their diet and therefore also needed to take calcium and vitamin D supplements. You should therefore ask your doctor if you need to take these supplements and also consider any other changes you could make to your lifestyle to reduce your risk of breaking a bone (see Section 9: "Other ways to help this condition"). Nonetheless it may not be possible to prevent every fracture.
For a complete list of possible side effects, see the consumer medicine information (CMI).
Talk to your doctor about the possible side effects of this medicine before you use it.
Always tell your doctor about any changes to your condition if you are taking a new medicine.
All medicines can have side effects. Sometimes the side effects are serious but most of the time they are not.
Problems with alendronate can range from nausea, vomiting and diarrhoea to more serious problems, such as inflammation and ulcers of the oesophagus (the tube which allows the passage of food from the throat to the stomach) and problems with the jaw.
The serious side effects to consider when deciding whether to use alendronate — or any other bisphosphonate — are oesophagus and rare jaw problems.
Because alendronate can irritate the oesophagus, you should not take this medicine if you:
Rarely, bisphosphonates can cause weakening of bone in the jaw. Jaw problems that might occur include delayed healing and infection, often after dental work or sores in the mouth (such as those caused by dentures). Jaw problems have mostly occurred in cancer patients receiving high dose injections of bisphosphonates, but they have very occasionally been reported with alendronate tablets.
Fortunately, these side effects can generally be avoided if you take some sensible precautions (see Section 6: "How to reduce your risk of side effects").
Do not take alendronate if:
Let your doctor know if you are taking anti-inflammatory medicines for joint or muscle pain, as these medicines may increase the risk of oesophagus problems when taken with alendronate.
To reduce the risk of irritation to your oesophagus, you should carefully follow the dosage instructions:
To help reduce the risk of jaw problems, such as infections and poor healing:
CMIs are available for most prescription medicines.
Read the Consumer Medicine Information (CMI) leaflet.
Before you start taking a new medicine, you should read the CMI. The CMI will tell you:
You can get the CMI for Alendronate from:
For a complete list of possible side effects, see the consumer medicine information (CMI).
Talk to your doctor about the possible side effects of this medicine before you use it.
Always tell your doctor about any changes to your condition if you are taking a new medicine.
People with osteoporosis, who have suffered a fracture due to minimal trauma (e.g. no apparent injury or a minor injury such as a fall from a standing height or less), have been able to obtain alendronate (taken as a once-weekly tablet) on the Pharmaceutical Benefit Scheme (PBS) for several years.
On 1 April 2007, PBS eligibility for alendronate was extended to include people with osteoporosis who have not yet had a fracture but are at high risk of having one. To qualify, you must meet both of the following conditions:
* For a medicine to be listed on the PBS it must be shown to be cost-effective. Whilst younger people with osteoporosis may also have a very low BMD, people over 70 years have an overall higher risk of fracture. The same benefits for reducing fracture risk have not been so clearly shown in people less than 70. Therefore alendronate is cost-effective and of most benefit to this older age group.
To coincide with changes to the PBS, on 1st April 2007, Medicare cover for bone mineral density scans was extended to include all people aged 70 years and older.
If you are eligible to receive alendronate under the PBS, you will need to pay an amount towards the cost
of each prescription. At time of publication, the patient contribution for each prescription was:
Fosamax Once Weekly attracts a Brand Price Premium of 72c, which means that the cost for Fosamax Once Weekly will be:
For people who receive concessional rates, the cost to the Government for each prescription is $41.99 for Fosamax Once Weekly and $41.27 for other brands of alendronate (once-weekly). For those who do not receive concessional rates for their prescriptions, the cost to the Government is $15.69 for Fosamax Once Weekly and $14.97 for other brands of alendronate (once-weekly).
For more information, contact Osteoporosis Australia on 1800 242 141 (free call in Australia).
Even if you are taking medicines for osteoporosis, there are other things you can do to help reduce your chance of fractures.
Osteoporosis Australia recommends that you:
Calcium is necessary for healthy bones. Three servings of dairy products a day (e.g. one serve = 250 mL milk, or 200 g tub of yoghurt, or 40 g cheddar cheese) will generally provide you with the recommended calcium intake. If your diet does not include enough calcium your doctor may recommend that you take calcium supplements.
Vitamin D is formed in the skin from sunlight exposure and plays an important role in increasing calcium absorption from foods. Ideally, you should get exposure to direct sunlight for 5–15 minutes, four to six times a week. However, avoid the hours of 10am–3pm, to reduce your risk of skin cancer. If you have dark skin, wear covered clothing, or are confined indoors for any reason your doctor may need to prescribe you a vitamin D supplement.
Regular exercise can help to maintain bone health and reduce your risk of falls. People with osteoporosis should undertake exercise that improves muscle strength and balance (e.g. Tai Chi) to help prevent falls (see 'attend a falls prevention program or clinic'). Avoid vigorous weight-bearing exercise or other physical activities that could cause a fall or fracture. If you have osteoporosis, you should first consult your doctor or physiotherapist before starting an exercise program. The exercise program should be carefully adjusted to suit your age and overall health, including bone health.
Poor leg muscle strength, poor balance and poor eyesight can increase your risk of having a fall. Even a minor fall can lead to a fracture in someone with osteoporosis. Ask your doctor if there are any fall prevention clinics in your area. Strength and balance exercise have been shown to reduce the risk of falling. You may need to discuss with your doctor reducing some of your other medications, particularly if you are taking sedatives or medications to help you sleep. (These medications have been shown to increase your risk of falling). Osteoporosis Australia offers many ideas on how to prevent falls, including tips on how to reduce fall hazards in the home.
If you smoke and/or drink excessive amounts of alcohol, you have a higher risk of fractures.
With alcohol, for example, it can make you drowsy and increase your chances of having a fall which can cause a fracture, especially if you are older.
Prescription medicines go through many tests and clinical trials before they can be prescribed in Australia. Sometimes, less common side effects do not become obvious until large numbers of people have used the medicine. (Note that alendronate is not a new drug. It has been used for at least 10 years for treating osteoporosis. However some of its rare side effects, such as problems in the jaw bone, have only recently been found).
All medicines go through four types of tests for their effectiveness, side effects and safety:
The Therapeutic Goods Administration (Australia’s regulatory agency for medicines) checks these results
before it approves the registration of the medicine for use in Australia.
Medicines are made available on the PBS if they are shown to be as good or better than other available medicines for the same condition.
Read the consumer medicine information (CMI) leaflet for this medicine. The CMI will tell you:
You can get the CMI leaflet for Alendronate from:
Call the Adverse Medicine Events (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm EST).
The AME Line lets you report and discuss side effects that might be related to your medicine. The side effects of your medicine — but not your personal details — are reported to the Australian medicines regulatory agency (the Therapeutic Goods Administration or TGA for short). The information helps to improve the safe use of medicines.
See AME Line for more information.
See About Medicine Update for more information about this publication.
Date published: 2008-01-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.